---
document_datetime: 2023-09-21 18:48:21
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/endolucinbeta-epar-all-authorised-presentations_en.pdf
document_name: endolucinbeta-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7442518
conversion_datetime: 2025-12-14 22:53:24.034207
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                     | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------|------------|-----------------------------------------|-----------------------|---------------------------|-------------|
| EU/1/16/1105/001 | EndolucinBeta     | 40 GBq/mL  | Radiopharmaceutical precursor, solution | vial (glass)          | 2 ml                      | 1 vial      |
| EU/1/16/1105/002 | EndolucinBeta     | 40 GBq/mL  | Radiopharmaceutical precursor, solution | vial (glass)          | 10 ml                     | 1 vial      |

,